Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Celularity (CELUW) Net Income towards Common Stockholders (2020 - 2025)

Historic Net Income towards Common Stockholders for Celularity (CELUW) over the last 6 years, with Q3 2025 value amounting to -$23.1 million.

  • Celularity's Net Income towards Common Stockholders fell 4331.06% to -$23.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$80.7 million, marking a year-over-year decrease of 13023.34%. This contributed to the annual value of -$57.9 million for FY2024, which is 7050.77% up from last year.
  • Celularity's Net Income towards Common Stockholders amounted to -$23.1 million in Q3 2025, which was down 4331.06% from -$24.5 million recorded in Q2 2025.
  • Celularity's 5-year Net Income towards Common Stockholders high stood at $49.9 million for Q3 2021, and its period low was -$93.9 million during Q3 2023.
  • Its 5-year average for Net Income towards Common Stockholders is -$21.4 million, with a median of -$19.8 million in 2025.
  • Its Net Income towards Common Stockholders has fluctuated over the past 5 years, first surged by 70480.2% in 2022, then plummeted by 205615.75% in 2023.
  • Celularity's Net Income towards Common Stockholders (Quarter) stood at -$4.0 million in 2021, then soared by 704.8% to $24.4 million in 2022, then crashed by 60.93% to $9.5 million in 2023, then crashed by 239.24% to -$13.3 million in 2024, then plummeted by 73.57% to -$23.1 million in 2025.
  • Its Net Income towards Common Stockholders was -$23.1 million in Q3 2025, compared to -$24.5 million in Q2 2025 and -$19.8 million in Q1 2025.